Aaysha Cader Profile picture
Cardiology•@Oxford_NDPH MSc•@SCAIWIN& Int'l•#EAPCI Comm•@worldheartfed EL•@apsc_office Young•SoMe editor @ESC_Journals @CCIjournal #JAPSC•@PCRonline JC•

Dec 3, 2021, 10 tweets

Despite ESC recommendations IABP remains most widely used MCS in Germany: European perspectives and trends in MCS by @alaide_chief
#CVCT #iCVCT @NavinKapur4 @thiele_holger @georgedangas @CVCTForum @Drroxmehran @ShrillaB @Babar_Basir @adityadoc1 @DrRaniKhatib @docbhardwaj

@NavinKapur4 gives the North American perspective of MCS and Cardiogenic shock & barriers to shock trial execution
#CVCT #iCVCT @alaide_chief @thiele_holger @georgedangas @CVCTForum @Drroxmehran @hvanspall @rachkataria @AHajduczok @DrRajivsankar @DrRaniKhatib @SantosGallegoMD

Chuck Simonton @Abiomed on challenges for screening pts with hemodynamic collapse for enrollment in #shock trials
#CVCT #iCVCT @alaide_chief @thiele_holger @georgedangas @CVCTForum @hvanspall @FaiezZANNAD @DrRajivsankar @DrRaniKhatib @docbhardwaj @ShahzebKhanMD @drdargaray

@georgedangas outlines the trial design of PROTECT IV: a trial to evaluate use of Hemodynamic support in PCI #CVCT #iCVCT PI @GreggWStone
@alaide_chief @thiele_holger @georgedangas @CVCTForum @mirvatalasnag @FaiezZANNAD
@DrRajivsankar @DrRaniKhatib @docbhardwaj
@drdargaray

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling